Impact Biomedical Inc. (IBO): who owns it and who trades it
As of Nov 3, 2026, IBO insiders reported 6 open-market sales worth $59.5K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Jason Grady (Director), with $32.5K.
Latest filing Nov 3, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
In the last 12 months, IBO insiders reported $0 of open-market purchases and $59.5K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Dss, Inc. | 10% owner | Sale | 156 | $7.06 | $1.1K | Form 4 |
| Sep 23, 2026 | Dss, Inc. | 10% owner | Sale | 27 | $6.95 | $188 | Form 4 |
| Sep 22, 2026 | Dss, Inc. | 10% owner | Sale | 723 | $0.55 | $398 | Form 4 |
| Mar 27, 2026 | Todd D Macko | CFO | Sale | 43,400 | $0.56 | $24.3K | Form 4 |
| Mar 25, 2026 | Todd D Macko | CFO | Sale | 1,600 | $0.60 | $960 | Form 4 |
| Mar 23, 2026 | Jason Grady | Director | Sale | 50,000 | $0.65 | $32.5K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Jason Grady | Director | – | $32.5K | Mar 23, 2026 |
| Todd D Macko | Chief Financial Officer | – | $25.3K | Mar 27, 2026 |
| Dss, Inc. | 10% owner | – | $1.7K | Sep 24, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
IBO short interest
24,619 IBO shares are sold short. Over the last 12 reports the number of shares short went down 62%.
As of Oct 30, 2026, 24,619 IBO shares were sold short, down 6.4% from the report before. At the average daily volume of 21,408 shares, buying them all back would take about 1.1 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 24,619 | – | -6% | 21,408 | 1.1 |
| Oct 15, 2026 | 26,292 | – | -13% | 12,841 | 2.0 |
| Sep 30, 2026 | 30,169 | – | -94% | 15,208 | 2.0 |
| Sep 15, 2026 | 43,916 | 0.49% | -2% | 530,594 | 1.0 |
| Aug 31, 2026 | 44,848 | 0.50% | -2% | 27,947 | 19.3 |
| Aug 14, 2026 | 45,554 | 0.51% | -1% | 41,408 | 13.2 |
| Jul 31, 2026 | 46,243 | 0.51% | -0% | 20,507 | 27.1 |
| Jul 15, 2026 | 46,450 | 0.52% | +0% | 55,705 | 10.0 |
| Jun 30, 2026 | 46,374 | 0.52% | -10% | 75,355 | 7.4 |
| Jun 15, 2026 | 51,750 | 0.58% | -17% | 96,609 | 6.4 |
| May 29, 2026 | 62,505 | 0.70% | -4% | 34,559 | 21.7 |
| May 15, 2026 | 65,325 | 0.73% | -23% | 57,414 | 13.7 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Impact Biomedical company events
Impact Biomedical filed 5 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 3, 2026.
- Nov 3, 2026AnnouncementShared information with investors. Filing
- Oct 9, 2026RulesChanged its bylaws or articles. Filing
- Sep 17, 2026AnnouncementShared information with investors. Filing
- Sep 15, 2026AnnouncementShared information with investors. Filing
- Mar 4, 2026AgreementAmendment to Merger and Share Exchange Agreement As previously disclosed, Impact BioMedical Inc., a Nevada corporation, is party to that certain Merger and Share Exchange Agreement, dated June 21, 2025, by and among Dr Ashleys Limited, a Cayman Islands exempted company limited by shares, Impact, Dr… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Impact Biomedical financials
Questions about Impact Biomedical Inc. (IBO) stock
Are IBO insiders buying or selling?
In the last 12 months, IBO insiders reported no open-market purchases and 6 sales worth $59.5K. The latest trade was on Sep 24, 2026. See every trade.
What is the short interest in IBO?
As of Oct 30, 2026, 24,619 IBO shares were sold short, down 6.4% from the report before. At the average daily volume of 21,408 shares, buying them all back would take about 1.1 trading days (days to cover). See the history.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.